Polpharma Biologics Revenue and Competitors
Estimated Revenue & Valuation
- Polpharma Biologics's estimated annual revenue is currently $100.7M per year.
- Polpharma Biologics's estimated revenue per employee is $77,500
Employee Data
- Polpharma Biologics has 1299 Employees.
- Polpharma Biologics grew their employee count by 10% last year.
Polpharma Biologics's People
Name | Title | Email/Phone |
---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Chief Staff, Polpharma Biologics Group B.V. | Reveal Email/Phone |
3 | Head CTO Office | Reveal Email/Phone |
4 | Head QA Operations | Reveal Email/Phone |
5 | VP Quality | Reveal Email/Phone |
6 | VP Clinical Development | Reveal Email/Phone |
7 | Head ePlant Systems | Reveal Email/Phone |
8 | Head Quality Compliance | Reveal Email/Phone |
9 | Head MS&T | Reveal Email/Phone |
10 | Head Quality Compliance and Quality Systems/QP | Reveal Email/Phone |
Polpharma Biologics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.7M | 177 | -12% | N/A | N/A |
#2 | $12.1M | 156 | 21% | N/A | N/A |
#3 | $10.7M | 138 | 8% | N/A | N/A |
#4 | $0.3M | 4 | -20% | N/A | N/A |
#5 | $100.7M | 1299 | 10% | N/A | N/A |
#6 | $8.3M | 107 | 1% | N/A | N/A |
#7 | $8.5M | 110 | 8% | N/A | N/A |
#8 | $104.3M | 841 | 3% | N/A | N/A |
#9 | $5.6M | 72 | 33% | N/A | N/A |
#10 | $8.7M | 112 | 38% | N/A | N/A |
What Is Polpharma Biologics?
At Polpharma Biologics we aim at improving patients'​ lives by developing and manufacturing affordable biological medicines, which will broaden access to safe, efficacious we well as innovative therapies for serious diseases. We have created a unique work environment in and around a diverse, international team of experienced professionals and young, talented scientists who share their knowledge and passion to build one of the leading biotech companies in the world. Polpharma Biologics is a biotech company with state-of-the-art facilities across Europe. Operating across international centers of excellence specialized in cell line development, product and process development, clinical manufacturing, commercial scale production and regulatory affairs, allows us to work and partner on our in-house biological pipeline (biosimilars and novelty drugs) and at the same time provide top-quality contract development and manufacturing services to the industry. Our customized CDMO services are available for both biosimilars and innovative molecules, including next-generation biologics. We apply cutting-edge technologies using state-of-the-art mammalian and microbial production equipment. Our wide and integrated competencies give the company a high potential for growth and excellent career opportunities for all employees. Our headquarter is based in Poland – in Gdańsk, beautiful and historic city where you can enjoy Baltic beaches. Check out yourself and join our biomoleCOOL team!
keywords:N/AN/A
Total Funding
1299
Number of Employees
$100.7M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Polpharma Biologics News
... through a joint venture between ATHOS and Polpharma Biologics; and a 75.1% share of Aristo Pharma, a fully owned subsidiary of ATHOS.